Screening compound: MDGSLYWHCJHBAA-INIZCTEOSA-N

Screening compound: MDGSLYWHCJHBAA-INIZCTEOSA-N
Screening compound: MDGSLYWHCJHBAA-INIZCTEOSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
MDGSLYWHCJHBAA-INIZCTEOSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y040-3093

Molecular Formula

C18H16N2O3 (C18 H16 N2 O3)

Compound Name

2-[(1H-indol-2-yl)formamido]-3-phenylpropanoic acid

IUPAC name

(2S)-2-[(1H-indol-2-yl)formamido]-3-phenylpropanoic acid

SMILES

OC(C(Cc1ccccc1)NC(c1cc(cccc2)c2[nH]1)=O)=O

InChI

InChI=1S/C18H16N2O3/c21-17(15-11-13-8-4-5-9-14(13)19-15)20-16(18(22)23)10-12-6-2-1-3-7-12/h1-9,11,16,19H,10H2,(H,20,21)(H,22,23)/t16-/m0/s1

InChI Key

MDGSLYWHCJHBAA-INIZCTEOSA-N

MDL Number (MFCD)

MDGSLYWHCJHBAA-INIZCTEOSA-N in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Cardiovascular Library (22201 compounds)

Indole Derivatives (10091 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Nuclear receptors
  • Phosphatases
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with MDGSLYWHCJHBAA-INIZCTEOSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound MDGSLYWHCJHBAA-INIZCTEOSA-N?
Check Price and Availability of MDGSLYWHCJHBAA-INIZCTEOSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of MDGSLYWHCJHBAA-INIZCTEOSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for MDGSLYWHCJHBAA-INIZCTEOSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for MDGSLYWHCJHBAA-INIZCTEOSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of MDGSLYWHCJHBAA-INIZCTEOSA-N available by request